Home/ Stocks/ OVID

Ovid Therapeutics Inc. Common Stock

OVID XNAS

$2.80 +0.07 (+2.56%) ▲ 15-min delayed

Open

$2.77

High

$2.85

Low

$2.70

Volume

1.52M

Market Cap

$484.50M

About Ovid Therapeutics Inc. Common Stock

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 23 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$7.25M	$-17,414,000	N/A
FY 2025	$7.25M	$-17,414,000	N/A
Q3 2025	$132.0K	$-12,158,000	N/A
Q1 2025	$130.0K	$-10,235,000	N/A

Related Market News

No specific coverage for OVID yet. Check out our latest market news or earnings calendar.

Get OVID Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Ovid Therapeutics Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.